Literature DB >> 8257719

Changes of n-3 and n-6 fatty acids in plasma and circulating cells of normal subjects, after prolonged administration of 20:5 (EPA) and 22:6 (DHA) ethyl esters and prolonged washout.

F Marangoni1, M T Angeli, S Colli, S Eligini, E Tremoli, C R Sirtori, C Galli.   

Abstract

Eight normal volunteers (four men and four women) were treated with 3 x 1 g capsules of n-3 fatty acid ethyl esters for a period of 18 weeks, followed by a 24 week washout. Fatty acids of plasma, platelets, monocytes and red blood cells were analyzed at 0, 6, 12 and 18 weeks of treatment and at 4, 14 and 24 weeks of washout. During treatment, accumulation of EPA in plasma and cells was almost maximal at 6 weeks, whereas that of DHA reached a peak at 18 weeks. Arachidonic acid declined somewhat at 12 weeks in plasma and more markedly at 18 weeks in red blood cells and monocytes. During washout, EPA returned rapidly toward pretreatment values in all compartments, but it remained significantly higher in plasma and platelets at the end of washout. DHA declined more slowly, maintaining higher than basal values in plasma and platelets and lower than basal in red blood cells, at the end of washout. Rebound increments of AA occurred in plasma. Finally, the plasma levels of AA, but not those of the n-3 fatty acids, were more markedly modified in males than in females. The presented results suggest interactions between circulating fatty acids in the different compartment after n-3 FA administration, and indicate that very long washouts are necessary for a complete recovery from the induced fatty acid modifications.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8257719     DOI: 10.1016/0005-2760(93)90049-f

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  26 in total

1.  Effect of eicosapentaenoic acid on the proliferation and incidence of apoptosis in the colorectal cell line HT29.

Authors:  R G Clarke; E K Lund; P Latham; A C Pinder; I T Johnson
Journal:  Lipids       Date:  1999-12       Impact factor: 1.880

Review 2.  Fish oil in critical illness: mechanisms and clinical applications.

Authors:  Renee D Stapleton; Julie M Martin; Konstantin Mayer
Journal:  Crit Care Clin       Date:  2010-07       Impact factor: 3.598

3.  Lipid composition of erythrocytes and thrombocytes of a subantarctic seabird, the king penguin.

Authors:  C Fayolle; C Leray; P Ohlmann; G Gutbier; J P Cazenave; C Gachet; R Groscolas
Journal:  Lipids       Date:  2000-04       Impact factor: 1.880

4.  Effects of cellular redox balance on induction of apoptosis by eicosapentaenoic acid in HT29 colorectal adenocarcinoma cells and rat colon in vivo.

Authors:  P Latham; E K Lund; J C Brown; I T Johnson
Journal:  Gut       Date:  2001-07       Impact factor: 23.059

Review 5.  Important differences exist in the dose-response relationship between diet and immune cell fatty acids in humans and rodents.

Authors:  Kevin Fritsche
Journal:  Lipids       Date:  2007-08-23       Impact factor: 1.880

6.  Bioequivalence of Docosahexaenoic acid from different algal oils in capsules and in a DHA-fortified food.

Authors:  Linda M Arterburn; Harry A Oken; James P Hoffman; Eileen Bailey-Hall; Gloria Chung; Dror Rom; Jacqueline Hamersley; Deanna McCarthy
Journal:  Lipids       Date:  2007-08-23       Impact factor: 1.880

7.  Relative bioavailability and pharmacokinetics of two oral formulations of docosahexaenoic acid/eicosapentaenoic acid after multiple-dose administration in healthy volunteers.

Authors:  Antonio Rusca; Andrea Francesco Daniele Di Stefano; Mira V Doig; Claudia Scarsi; Emilio Perucca
Journal:  Eur J Clin Pharmacol       Date:  2009-01-16       Impact factor: 2.953

8.  Dietary intake of fish vs. formulations leads to higher plasma concentrations of n-3 fatty acids.

Authors:  Francesco Visioli; Patrizia Risé; Maria C Barassi; Franca Marangoni; Claudio Galli
Journal:  Lipids       Date:  2003-04       Impact factor: 1.880

9.  Identification of the Eph receptor pathway as a novel target for eicosapentaenoic acid (EPA) modification of gene expression in human colon adenocarcinoma cells (HT-29).

Authors:  Joanne F Doleman; John J Eady; Ruan M Elliott; Rob J Foxall; John Seers; Ian T Johnson; Elizabeth K Lund
Journal:  Nutr Metab (Lond)       Date:  2010-07-12       Impact factor: 4.169

10.  The role of omega-3 dietary supplementation in blepharitis and meibomian gland dysfunction (an AOS thesis).

Authors:  Marian S Macsai
Journal:  Trans Am Ophthalmol Soc       Date:  2008
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.